Matches in Wikidata for { <http://www.wikidata.org/entity/Q92997256> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- Q92997256 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q92997256 description "im Juni 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92997256 description "scientific article published on 22 June 2019" @default.
- Q92997256 description "wetenschappelijk artikel" @default.
- Q92997256 description "наукова стаття, опублікована 22 червня 2019" @default.
- Q92997256 name "Safety, immunogenicity and lot-to-lot consistency of a new Bivalent Oral Polio Vaccine (bOPV) in healthy Infants: Results of a Phase III, observer blind, randomized, controlled clinical study" @default.
- Q92997256 name "Safety, immunogenicity and lot-to-lot consistency of a new Bivalent Oral Polio Vaccine (bOPV) in healthy Infants: Results of a Phase III, observer blind, randomized, controlled clinical study" @default.
- Q92997256 type Item @default.
- Q92997256 label "Safety, immunogenicity and lot-to-lot consistency of a new Bivalent Oral Polio Vaccine (bOPV) in healthy Infants: Results of a Phase III, observer blind, randomized, controlled clinical study" @default.
- Q92997256 label "Safety, immunogenicity and lot-to-lot consistency of a new Bivalent Oral Polio Vaccine (bOPV) in healthy Infants: Results of a Phase III, observer blind, randomized, controlled clinical study" @default.
- Q92997256 prefLabel "Safety, immunogenicity and lot-to-lot consistency of a new Bivalent Oral Polio Vaccine (bOPV) in healthy Infants: Results of a Phase III, observer blind, randomized, controlled clinical study" @default.
- Q92997256 prefLabel "Safety, immunogenicity and lot-to-lot consistency of a new Bivalent Oral Polio Vaccine (bOPV) in healthy Infants: Results of a Phase III, observer blind, randomized, controlled clinical study" @default.
- Q92997256 P1433 Q92997256-F8EF3450-7DF4-490A-818E-854CA3FC19B3 @default.
- Q92997256 P1476 Q92997256-D9547A4A-620A-41E1-988B-4162C1FF615D @default.
- Q92997256 P2093 Q92997256-00DC252C-29B1-4827-B9B7-F49478ABBB31 @default.
- Q92997256 P2093 Q92997256-5165E317-DABC-42B0-ADD9-1659CFB85FEF @default.
- Q92997256 P2093 Q92997256-59DD2665-B62B-4C99-B2FE-F346957926D5 @default.
- Q92997256 P2093 Q92997256-6F523F91-FF16-48DA-A5B3-4BF8AB003136 @default.
- Q92997256 P2093 Q92997256-73FD1DF5-E3F4-4994-B122-CBA2A6690757 @default.
- Q92997256 P2093 Q92997256-84C67F8F-F262-4554-89EE-F9C36C332C33 @default.
- Q92997256 P2093 Q92997256-B3EDD010-81FE-4ED9-87E2-33F0CBA9FFDA @default.
- Q92997256 P2860 Q92997256-442A03F8-D9AC-40ED-9C79-D32D8A721E1B @default.
- Q92997256 P2860 Q92997256-610789F4-A262-418A-A9C5-AD58A26C61C7 @default.
- Q92997256 P2860 Q92997256-6B2A1D6E-3208-410E-8CEA-ABB1EBA2160C @default.
- Q92997256 P2860 Q92997256-A2427452-D741-4093-BAD3-7C720FDC244A @default.
- Q92997256 P2860 Q92997256-B43FD99E-80BA-4297-93B6-F685F65F2E2E @default.
- Q92997256 P2860 Q92997256-C991E962-0D65-4145-A569-7C73F32E852D @default.
- Q92997256 P2860 Q92997256-E5C2781A-22C9-4FF4-8293-401B517AE535 @default.
- Q92997256 P2860 Q92997256-FE5F477C-3633-42A6-8045-79FA1437FFE6 @default.
- Q92997256 P304 Q92997256-B4EED44E-F073-4747-8764-7C8D90F6B02E @default.
- Q92997256 P31 Q92997256-215D5809-73DB-44E9-947E-9EDF29E0D48A @default.
- Q92997256 P356 Q92997256-7D35C282-9DB4-4FC8-85C3-F24713F105FE @default.
- Q92997256 P433 Q92997256-EABD7D32-8AE7-4814-A14E-F87C26D5EDD3 @default.
- Q92997256 P478 Q92997256-D586A29C-F7CC-410D-B6E5-D588A961C6DC @default.
- Q92997256 P50 Q92997256-6A768529-2D1E-4DCF-87AB-3B8F6C87F606 @default.
- Q92997256 P577 Q92997256-CF291488-3019-4F6A-9224-A927C2F6FF3C @default.
- Q92997256 P698 Q92997256-CF9A0D63-747C-44E6-9F08-C6DE98D5EC38 @default.
- Q92997256 P921 Q92997256-112640BC-9B9E-4C95-9C28-AA23BD8DC890 @default.
- Q92997256 P356 J.VACCINE.2019.06.048 @default.
- Q92997256 P698 31235374 @default.
- Q92997256 P1433 Q7907941 @default.
- Q92997256 P1476 "Safety, immunogenicity and lot-to-lot consistency of a new Bivalent Oral Polio Vaccine (bOPV) in healthy Infants: Results of a Phase III, observer blind, randomized, controlled clinical study" @default.
- Q92997256 P2093 "Bhagwat Gunale" @default.
- Q92997256 P2093 "Dirk Mekkes" @default.
- Q92997256 P2093 "Ineke van Straaten" @default.
- Q92997256 P2093 "Md Yunus" @default.
- Q92997256 P2093 "Prasad S Kulkarni" @default.
- Q92997256 P2093 "Robert Kingma" @default.
- Q92997256 P2093 "Xandra Bouwstra" @default.
- Q92997256 P2860 Q36279108 @default.
- Q92997256 P2860 Q40071758 @default.
- Q92997256 P2860 Q40520483 @default.
- Q92997256 P2860 Q40664092 @default.
- Q92997256 P2860 Q41206694 @default.
- Q92997256 P2860 Q41654818 @default.
- Q92997256 P2860 Q47583783 @default.
- Q92997256 P2860 Q82078216 @default.
- Q92997256 P304 "4275-4280" @default.
- Q92997256 P31 Q13442814 @default.
- Q92997256 P356 "10.1016/J.VACCINE.2019.06.048" @default.
- Q92997256 P433 "31" @default.
- Q92997256 P478 "37" @default.
- Q92997256 P50 Q92781211 @default.
- Q92997256 P577 "2019-06-22T00:00:00Z" @default.
- Q92997256 P698 "31235374" @default.
- Q92997256 P921 Q1519099 @default.